Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024
Inspire Medical Systems (NYSE: INSP) announced it will release its second quarter 2024 financial results on August 6, 2024, after market close. Following the release, the management team will host a conference call at 5:00 p.m. Eastern Time to discuss results and recent business developments. The webcast will be accessible via Inspire's Investor Relations page. Questions for management can be submitted through a provided registration link, which will generate a unique access code for the live call. A replay of the call will be available approximately two hours after the event and will remain accessible for two weeks on the company's website.
- Upcoming financial results release potentially brings positive business updates.
- Access to the conference call and replay enhances transparency and investor relations.
- None.
MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, August 6. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q2 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
![](https://ml.globenewswire.com/media/MjI5OTE3YTgtZGFiOC00ZGM2LWI0NjctM2EwMTIwNzFiYzljLTExODkzODU=/tiny/Inspire-Medical-Systems.png)
FAQ
When will Inspire Medical Systems report Q2 2024 financial results?
How can I access the Inspire Medical Systems Q2 2024 earnings call?
What time is the Inspire Medical Systems Q2 2024 earnings conference call?
How can I submit questions for the Inspire Medical Systems Q2 2024 earnings call?